Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

20.64
Delayed Data
As of 4:00pm ET
 +0.27 / +1.33%
Today’s Change
9.51
Today|||52-Week Range
23.30
+53.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues35.1M38.6M42.7M43.1M
 
 
 
 
 
Cost of Goods Sold1.5M2.0M2.5M1.6M
 
 
 
 
 
Depreciation And Amortization217.0K220.0K270.0K429.0K
 
 
 
 
 
 
Operating ExpensesGross Income33.3M36.3M39.9M41.0M
 
 
 
 
 
General Expenses30.2M32.0M33.0M35.7M
 
 
 
 
 
Research And Development6.9M9.1M9.4M10.6M
 
 
 
 
 
Total Operating Expenses32.0M34.3M35.8M37.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.1M4.3M6.8M5.3M
 
 
 
 
 
Extraordinary Credit1.0K114.0K189.0K101.0K
 
 
 
 
 
Extraordinary Charge-241.0K-25.0K---382.0K
 
 
 
 
Interest Expense On Debt331.0K292.0K225.0K179.0K
 
 
 
 
 
Other Expenses25.0K5.0K8.0K-4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.7M4.3M7.0M5.2M
 
 
 
 
 
Income Taxes-662.0K-58.0K-174.0K-198.0K
 
 
 
 
 
Net Income2.0M4.2M6.9M5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.9M48.5M48.9M49.2M
 
 
 
 
 
Shares To Calculate EPS Diluted52.3M51.6M49.6M51.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.03$0.08$0.14$0.08
 
 
 
 
 
EPS Diluted$0.04$0.08$0.14$0.08